Dare Bioscience annual debt-to-equity ratio
2018
2019
2021
2022
2025
Dare Bioscience Debt-to-Equity Ratio Growth & History (DARE)
Dare Bioscience's debt-to-equity ratio was 0.93 for fiscal 2025.
View full Dare Bioscience company overviewDare Bioscience annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.93 | — | — |
| 2022 | 2022-12-31 | 0.04 | 0.04 | +530.47% |
| 2021 | 2021-12-31 | 0.01 | — | — |
| 2019 | 2019-12-31 | 1.81 | 1.76 | +3038.12% |
| 2018 | 2018-12-31 | 0.06 | — | — |
Dare Bioscience quarterly debt-to-equity ratio
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.24
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 2.20 | — | — |
| Q4 2025 | 2025-12-31 | 0.93 | — | — |
| Q3 2025 | 2025-09-30 | 1.03 | — | — |
| Q2 2024 | 2024-06-30 | 0.57 | — | — |
| Q1 2023 | 2023-03-31 | 0.08 | 0.04 | +102.07% |
| Q4 2022 | 2022-12-31 | 0.04 | 0.04 | +530.47% |
| Q3 2022 | 2022-09-30 | 0.02 | 0.01 | +83.78% |
| Q2 2022 | 2022-06-30 | 0.03 | −0.03 | −45.30% |
| Q1 2022 | 2022-03-31 | 0.04 | −0.14 | −78.61% |
| Q4 2021 | 2021-12-31 | 0.01 | — | — |
| Q3 2021 | 2021-09-30 | 0.01 | — | — |
| Q2 2021 | 2021-06-30 | 0.06 | −1.84 | −96.66% |
| Q1 2021 | 2021-03-31 | 0.18 | −0.03 | −14.67% |
| Q2 2020 | 2020-06-30 | 1.90 | 1.86 | +4898.89% |
| Q1 2020 | 2020-03-31 | 0.21 | 0.16 | +263.33% |
| Q4 2019 | 2019-12-31 | 1.81 | 1.76 | +3038.12% |
| Q3 2019 | 2019-09-30 | 0.10 | — | — |
| Q2 2019 | 2019-06-30 | 0.04 | — | — |
| Q1 2019 | 2019-03-31 | 0.06 | — | — |
| Q4 2018 | 2018-12-31 | 0.06 | — | — |
Dare Bioscience debt-to-equity ratio trends
Between the periods ended 2018-12-31 and 2025-12-31, Dare Bioscience's debt-to-equity ratio increased from 0.06 to 0.93, a change of 0.88. The latest reported quarter, Q1 2026, shows 2.20.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dare Bioscience source filings ↗